Losartan decreases hemoglobin in renal transplant recipients

A significant decrease in hematocrit has been observed with the use of ACE inhibitors in renal transplant patients. Mechanisms whereby ACR inhibitors decrease the hematocrit in renal transplant patients are unknown even when several studies have focused on interactions between erythropoietin product...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Transplantation proceedings 1997-08, Vol.29 (5), p.2402-2403
Hauptverfasser:	Ducloux, D., Chalopin, J.M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiotensin-Converting Enzyme Inhibitors - pharmacology Biological and medical sciences Biphenyl Compounds - pharmacology Drug toxicity and drugs side effects treatment Hemoglobins - analysis Humans Imidazoles - pharmacology Kidney Transplantation Losartan Medical sciences Pharmacology. Drug treatments Tetrazoles - pharmacology Toxicity: urogenital system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!